News + Filings Transactions Holdings
All 13F 13D/G Other
|
New Enterprise Associates 14, L.P.
|
Create: Alert |
All | News | Filings
Date Filed | Type | Description |
01/04/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
04/07/2022 |
4
| New Enterprise Associates 14, L.P. (10% Owner) has filed a Form 4 on IMARA Inc.
Txns:
| Sold 439,088 shares
@ $1.0691, valued at
$469.4k
Sold 255,463 shares
@ $1.1032, valued at
$281.8k
|
|
01/26/2022 |
4
| New Enterprise Associates 14, L.P. (10% Owner) has filed a Form 4 on Casper Sleep Inc.
Txns:
| Unknown transaction of 6,222,502 shares
@ $6.9, valued at
$42.9M
|
|
01/25/2022 |
4
| New Enterprise Associates 14, L.P. (10% Owner) has filed a Form 4 on IMARA Inc.
Txns:
| Sold 11,622 shares
@ $1.6683, valued at
$19.4k
Sold 19,984 shares
@ $1.5521, valued at
$31k
Sold 102,952 shares
@ $1.4745, valued at
$151.8k
|
|
01/20/2022 |
4
| New Enterprise Associates 14, L.P. (10% Owner) has filed a Form 4 on IMARA Inc.
Txns:
| Sold 6,848 shares
@ $1.8877, valued at
$12.9k
Sold 13,412 shares
@ $1.8203, valued at
$24.4k
Sold 6,295 shares
@ $1.8086, valued at
$11.4k
|
|
01/14/2022 |
4
| New Enterprise Associates 14, L.P. (10% Owner) has filed a Form 4 on IMARA Inc.
Txns:
| Sold 4,634 shares
@ $2.0193, valued at
$9.4k
Sold 7,209 shares
@ $1.9262, valued at
$13.9k
Sold 9,707 shares
@ $1.9144, valued at
$18.6k
|
|
01/11/2022 |
4
| New Enterprise Associates 14, L.P. (10% Owner) has filed a Form 4 on IMARA Inc.
Txns:
| Sold 14,600 shares
@ $2.0766, valued at
$30.3k
Sold 1,751 shares
@ $2, valued at
$3.5k
Sold 2,409 shares
@ $2.0421, valued at
$4.9k
|
|
01/06/2022 |
4
| New Enterprise Associates 14, L.P. (10% Owner) has filed a Form 4 on IMARA Inc.
Txns:
| Sold 13,459 shares
@ $2.3437, valued at
$31.5k
Sold 8,200 shares
@ $2.2487, valued at
$18.4k
Sold 10,257 shares
@ $2.1649, valued at
$22.2k
|
|
01/03/2022 |
4
| New Enterprise Associates 14, L.P. (10% Owner) has filed a Form 4 on IMARA Inc.
Txns:
| Sold 21,858 shares
@ $2.2905, valued at
$50.1k
Sold 49,953 shares
@ $2.2503, valued at
$112.4k
Sold 44,665 shares
@ $2.3373, valued at
$104.4k
|
|
12/29/2021 |
4
| New Enterprise Associates 14, L.P. (10% Owner) has filed a Form 4 on IMARA Inc.
Txns:
| Sold 27,651 shares
@ $2.4233, valued at
$67k
Sold 24,580 shares
@ $2.3409, valued at
$57.5k
Sold 15,196 shares
@ $2.3002, valued at
$35k
|
|
12/27/2021 |
4
| New Enterprise Associates 14, L.P. (10% Owner) has filed a Form 4 on IMARA Inc.
Txns:
| Sold 5,666 shares
@ $2.9462, valued at
$16.7k
Sold 8,667 shares
@ $2.8316, valued at
$24.5k
Sold 17,501 shares
@ $2.8317, valued at
$49.6k
Sold 15,093 shares
@ $2.5603, valued at
$38.6k
Sold 28,817 shares
@ $2.2794, valued at
$65.7k
Sold 44,993 shares
@ $2.2347, valued at
$100.5k
Sold 47,000 shares
@ $2.2103, valued at
$103.9k
Sold 38,123 shares
@ $2.3272, valued at
$88.7k
Sold 41,222 shares
@ $2.3241, valued at
$95.8k
Sold 20,109 shares
@ $2.3213, valued at
$46.7k
Sold 23,961 shares
@ $2.41, valued at
$57.7k
|
|
09/16/2020 |
4
| New Enterprise Associates 14, L.P. (10% Owner) has filed a Form 4 on Mersana Therapeutics, Inc.
Txns:
| Disposed of 2,000,000 shares
@ $0 |
|
05/22/2020 |
4
| New Enterprise Associates 14, L.P. (10% Owner) has filed a Form 4 on Surface Oncology, Inc.
Txns:
| Sold 420,000 shares
@ $3.6561, valued at
$1.5M
|
|
04/13/2020 |
4
| New Enterprise Associates 14, L.P. (10% Owner) has filed a Form 4 on Mersana Therapeutics, Inc.
Txns:
| Disposed of 4,000,000 shares
@ $0 |
|
04/13/2020 |
4
| New Enterprise Associates 14, L.P. (10% Owner) has filed a Form 4 on Mersana Therapeutics, Inc.
Txns:
| Sold 1,211 shares
@ $2.91, valued at
$3.5k
Exercised (in-or-at-the-money) 70,593 options to buy
@ $0.05, valued at
$3.5k
|
|
03/16/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
03/10/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
02/12/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
11/12/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
11/04/2019 |
4
| New Enterprise Associates 14, L.P. (10% Owner) has filed a Form 4 on Oyster Point Pharma, Inc.
Txns:
| Converted 3,606,282 shares
@ $0 Converted 1,061,547 shares
@ $0 Bought 935,000 shares
@ $16, valued at
$15M
Converted 3,606,282 convertible preferred
@ $0 Converted 1,061,547 convertible preferred
@ $0 |
|
03/06/2019 |
4
| New Enterprise Associates 14, L.P. (10% Owner) has filed a Form 4 on Mersana Therapeutics, Inc.
Txns:
| Bought 3,750,000 shares
@ $4, valued at
$15M
|
|
09/10/2018 |
4
| New Enterprise Associates 14, L.P. (10% Owner) has filed a Form 4 on Adaptimmune Therapeutics PLC
Txns:
| Bought 3,000,000 shares
@ $1.6667, valued at
$5M
|
|
05/09/2018 |
4
| New Enterprise Associates 14, L.P. (10% Owner) has filed a Form 4 on MULESOFT, INC
Txns:
| Converted 12,679,970 shares
@ $0 Unknown transaction of 12,679,970 shares
@ $0 Converted 12,679,970 options to buy
@ $0 |
|
04/23/2018 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
03/28/2018 |
4
| New Enterprise Associates 14, L.P. (10% Owner) has filed a Form 4 on Adaptimmune Therapeutics PLC
Txns:
| Bought 571,164 shares
@ $1.9041, valued at
$1.1M
Bought 6,000,000 shares
@ $1.9167, valued at
$11.5M
|
|
03/27/2018 |
4
| New Enterprise Associates 14, L.P. (10% Owner) has filed a Form 4 on Tracon Pharmaceuticals, Inc.
Txns:
| Bought 707,964 shares
@ $2.7, valued at
$1.9M
Bought 707,964 options to buy
@ $2.7, valued at
$1.9M
|
|
03/23/2018 |
4
| New Enterprise Associates 14, L.P. (10% Owner) has filed a Form 4 on Adaptimmune Therapeutics PLC
Txns:
| Bought 104,844 shares
@ $1.8105, valued at
$189.8k
Bought 869,574 shares
@ $1.904, valued at
$1.7M
Bought 294,090 shares
@ $1.9462, valued at
$572.4k
|
|
02/15/2018 |
4
| New Enterprise Associates 14, L.P. (10% Owner) has filed a Form 4 on APPIAN CORP
Txns:
| Converted 2,724,202 shares
@ $0 Disposed of 2,724,202 shares
@ $0 Converted 2,724,202 options to buy
@ $0 |
|
01/26/2018 |
4
| New Enterprise Associates 14, L.P. (10% Owner) has filed a Form 4 on SYNLOGIC, INC.
Txns:
| Granted 410,000 shares
@ $9.75, valued at
$4M
|
|
11/27/2017 |
4
| New Enterprise Associates 14, L.P. (10% Owner) has filed a Form 4 on APPIAN CORP
Txns:
| Converted 569,620 shares
@ $0 Sold 569,620 shares
@ $19.49, valued at
$11.1M
Converted 569,620 options to buy
@ $0 |
|
11/21/2017 |
4
| New Enterprise Associates 14, L.P. (10% Owner) has filed a Form 4 on APPIAN CORP
Txns:
| Converted 2,820,516 shares
@ $0 Sold 2,820,516 shares
@ $19.49, valued at
$55M
Converted 2,820,516 options to buy
@ $0 |
|
08/30/2017 |
4
| New Enterprise Associates 14, L.P. (10% Owner) has filed a Form 4 on SYNLOGIC, INC.
Txns:
| Granted 3,394,439 shares
@ $0 |
|
07/06/2017 |
4
| New Enterprise Associates 14, L.P. (10% Owner) has filed a Form 4 on Mersana Therapeutics, Inc.
Txns:
| Converted 7,140,138 shares
@ $0 Bought 1,000,000 shares
@ $15, valued at
$15M
Converted 11,931,173 preferred shares
@ $0 Converted 18,001,419 preferred shares
@ $0 Converted 2,216,626 preferred shares
@ $0 |
|
05/31/2017 |
4
| New Enterprise Associates 14, L.P. (10% Owner) has filed a Form 4 on APPIAN CORP
Txns:
| Converted 6,114,338 convertible preferred
@ $0 Converted 6,114,338 options to buy
@ $0 |
|
|
|
|